ATE484290T1 - Peptid mit antitumoraler wirkung - Google Patents

Peptid mit antitumoraler wirkung

Info

Publication number
ATE484290T1
ATE484290T1 AT05823400T AT05823400T ATE484290T1 AT E484290 T1 ATE484290 T1 AT E484290T1 AT 05823400 T AT05823400 T AT 05823400T AT 05823400 T AT05823400 T AT 05823400T AT E484290 T1 ATE484290 T1 AT E484290T1
Authority
AT
Austria
Prior art keywords
peptide
peptides
tumoral effect
analogs
fragments
Prior art date
Application number
AT05823400T
Other languages
German (de)
English (en)
Inventor
Martin Rosenberg
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Application granted granted Critical
Publication of ATE484290T1 publication Critical patent/ATE484290T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05823400T 2004-11-08 2005-11-04 Peptid mit antitumoraler wirkung ATE484290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62622004P 2004-11-08 2004-11-08
PCT/US2005/040078 WO2006052775A2 (en) 2004-11-08 2005-11-04 Peptide anti - tumor agent

Publications (1)

Publication Number Publication Date
ATE484290T1 true ATE484290T1 (de) 2010-10-15

Family

ID=36337037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05823400T ATE484290T1 (de) 2004-11-08 2005-11-04 Peptid mit antitumoraler wirkung

Country Status (7)

Country Link
US (3) US7173110B2 (enExample)
EP (1) EP1812035B1 (enExample)
JP (2) JP5138378B2 (enExample)
AT (1) ATE484290T1 (enExample)
CA (1) CA2584805C (enExample)
DE (1) DE602005024161D1 (enExample)
WO (1) WO2006052775A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7173110B2 (en) * 2004-11-08 2007-02-06 New York University Peptide anti-tumor agent
WO2010120691A2 (en) * 2009-04-13 2010-10-21 Elc Management Llc Methionine sulfoxide peptide, compositions and methods of use
MX346043B (es) * 2012-01-06 2017-03-03 Novus Int Inc Tensioactivos basados en sulfoxido.
RU2620170C1 (ru) * 2016-08-02 2017-05-23 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России Применение катионных пептидов для индукции гибели клеток меланомы кожи человека
US10584306B2 (en) 2017-08-11 2020-03-10 Board Of Regents Of The University Of Oklahoma Surfactant microemulsions
EP3911662A4 (en) * 2019-01-14 2022-10-26 New York University CYCLIC PEPTIDE DIMERS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4307082A (en) 1979-07-10 1981-12-22 New York University Method for the extraction of a factor that mediates contact inhibition of cell growth
US4530784A (en) 1983-08-19 1985-07-23 New York University Large scale extraction process for contact inhibitory factor
DE3841763A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
US5942492A (en) * 1996-11-12 1999-08-24 Angstrom Pharmaceuticals, Inc. Cyclic peptides that bind to urokinase-type plasminogen activator receptor
US20050124531A1 (en) * 2002-02-22 2005-06-09 New York University Biological inhibitions induced by contact inhibitory factor
JP2004083427A (ja) * 2002-08-23 2004-03-18 Microbial Chem Res Found 環状ヘキサペプチド及びプロテアソーム阻害剤
US7173110B2 (en) * 2004-11-08 2007-02-06 New York University Peptide anti-tumor agent

Also Published As

Publication number Publication date
US7173110B2 (en) 2007-02-06
JP2013005804A (ja) 2013-01-10
US20070123454A1 (en) 2007-05-31
EP1812035A2 (en) 2007-08-01
WO2006052775A3 (en) 2006-07-20
JP2008518622A (ja) 2008-06-05
CA2584805A1 (en) 2006-05-18
EP1812035A4 (en) 2008-04-16
WO2006052775A2 (en) 2006-05-18
US20060258573A1 (en) 2006-11-16
EP1812035B1 (en) 2010-10-13
CA2584805C (en) 2014-01-28
US8003598B2 (en) 2011-08-23
JP5138378B2 (ja) 2013-02-06
US7691964B2 (en) 2010-04-06
DE602005024161D1 (de) 2010-11-25
US20100305044A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
NZ534919A (en) Bioactive keratin peptides
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
BR112012011332A2 (pt) agentes direcionados para gadd45beta
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
EA200500871A1 (ru) Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
CY1105616T1 (el) ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1
FR2835528B1 (fr) Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
CY1118930T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων
DE602004014145D1 (de) Von rasgap-abgeleitetes peptid zur gezielten tötung von krebszellen
NO20062198L (no) Bradykinin B1 reseptorantagonister
HRP20050024A2 (en) Pegylated t20 polypeptide
DE602005024161D1 (de) Peptid mit antitumoraler wirkung
DE60229867D1 (de) Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
AU2003260452A8 (en) Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
IT1294967B1 (it) Composizione immunogenica da tlp
WO2006122162A3 (en) Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
ES2164011B1 (es) Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos.
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
DE10394174D2 (de) Peptide mit hohem Cysteingehalt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties